-
ImmunityBio's (IBRX) Buy Rating Reaffirmed at D. Boral Capital
Source: Buzz FX / 14 Mar 2025 10:37:16 America/New_York
ImmunityBio's (IBRX) Buy Rating Reaffirmed at D. Boral Capital Written by MarketBeat March 14, 2025 Share Link copied to clipboard. Remove Ads ImmunityBio ( NASDAQ:IBRX - Get Free Report ) 's stock had its "buy" rating reaffirmed by analyst
Read more...